Private Market View

Element Biosciences

Other Healthcare Technology Systems · San Diego, CA · Founded 2017 · Privately Held (backing)

PA Mark · $/share
$12
Sep 2026
Implied valuation
$1.0B
Total raised
$683.3M
Last round
Later Stage VC (Series D)
Jul 2024

Key facts

as of Sep 2026
  • Element Biosciences’s last known valuation is $1.0B.
  • It has raised $683.3M across 2 recorded rounds; the latest was Later Stage VC (Series D) ($277.0M) in Jul 2024.
  • Notable investors include Fidelity Management & Research Company, RA Capital Management, CONNECT(San Diego), Alexandria Venture Investments, Venrock15 tracked in total.
  • 3 institutional filers report fund marks on Element Biosciences across 35 filings.
  • Status: Privately Held (backing).
PA Mark — composite indicative price
LOW confidence
~$12per share
as of Sep 2026 · the exact daily mark is a member feature
Composed from 2 inputs:N-PORT marks 100%
Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·The complete investor list — 15 names
  • ·Watchlist + deal alerts for Element Biosciences
Create free account
No card required

Recorded secondary trades

No prints on record

No secondary trades in Element Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

3 filers · latest Jun 2026

3 SEC-registered funds reported 35 fair-value marks on Element Biosciences between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.

Funding rounds

2 rounds
Jul 2024Later Stage VC (Series D)$277.0M
Jun 2021Later Stage VC (Series C)$276.0M

About Element Biosciences

Developer of genetic analysis tools intended to be used for the research and diagnostic markets. The company's technology develops a modular and high-performing DNA sequencing platform that will deliver quality data, workflow flexibility, and make next-generation sequencing technology more accessible, enabling medical researchers to benefit from and improve their research.

Industry
Other Healthcare Technology Systems
Sector
Healthcare
HQ
San Diego, CA, United States
Founded
2017
Employees
407
Ownership
Privately Held (backing)